Smruthi Organics Ltd

Smruthi Organic Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Smruthi Organics Ltd

₹ 172 1.75%
18 May - close price
smruthiorganics.com BSE: 540686
About

Incorporated in 1989, Smruthi Organics Limited is engaged in the business of manufacturing and marketing active pharmaceutical ingredients (APIs) and intermediates. The company supplies its products to the domestic pharmaceutical companies as well as exports to semi regulatory markets in Asia, Americas and Africa.[1]

Key Points

Product Info:[1]
The company manufactures API products in the anti–diabetic, anti–hypertension and anti–infectives therapeutic categories. The product portfolio of the company consists of more than 12 APIs and intermediates including- Metformin HCL, Teneligliptin, Vildagliptin, Diloxanide Furoate, Norfloxacin, Telmisartan, Amlodipine Besylate, Amlodipine Malelate, Potassium Losartan, Valsartan, Ciprofloxacin HCL and Pefloxacin Mesylate.
In FY23, company has developed 3 APIs and 7 critical intermediates. Company has filed 11 Drug Master Files (DMF) covering 5 products in 8 countries globally[2]

Website BSE
  • Market Cap ₹ 197 Cr.
  • Current Price ₹ 172
  • High / Low ₹ 219 / 117
  • Stock P/E 54.8
  • Book Value ₹ 60.8
  • Dividend Yield 1.16 %
  • ROCE 8.22 %
  • ROE 5.21 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has been maintaining a healthy dividend payout of 45.5%

Cons

  • Stock is trading at 2.83 times its book value
  • The company has delivered a poor sales growth of -1.46% over past five years.
  • Company has a low return on equity of 9.03% over last 3 years.
  • Debtor days have increased from 97.0 to 117 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
28.72 30.90 30.55 36.45 35.47 29.07 43.27 31.92 36.78 34.91 29.59 23.48 39.66
23.27 26.46 25.82 30.47 31.83 27.35 39.23 30.24 34.53 30.29 25.16 24.66 35.58
Operating Profit 5.45 4.44 4.73 5.98 3.64 1.72 4.04 1.68 2.25 4.62 4.43 -1.18 4.08
OPM % 18.98% 14.37% 15.48% 16.41% 10.26% 5.92% 9.34% 5.26% 6.12% 13.23% 14.97% -5.03% 10.29%
0.19 0.18 0.22 0.08 0.10 0.03 0.02 0.01 0.05 0.01 0.00 0.00 0.06
Interest 0.23 0.23 0.30 0.34 0.12 0.12 0.22 0.24 0.25 0.33 0.39 0.32 0.37
Depreciation 0.90 1.05 1.05 1.05 1.11 1.11 1.06 1.16 1.24 1.24 1.38 1.45 1.59
Profit before tax 4.51 3.34 3.60 4.67 2.51 0.52 2.78 0.29 0.81 3.06 2.66 -2.95 2.18
Tax % 29.49% 24.25% 22.22% 23.34% 31.08% 40.38% -3.24% 34.48% 14.81% 25.49% 22.56% 22.03% 30.73%
3.17 2.53 2.80 3.58 1.73 0.30 2.87 0.19 0.69 2.29 2.07 -2.29 1.52
EPS in Rs 2.77 2.21 2.45 3.13 1.51 0.26 2.51 0.17 0.60 2.00 1.81 -2.00 1.33
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
181 92 77 74 79 97 137 131 126 133 141 128
162 90 72 63 69 94 121 116 98 115 131 116
Operating Profit 19 2 5 11 10 3 17 15 29 18 10 12
OPM % 10% 2% 6% 14% 13% 3% 12% 12% 23% 14% 7% 9%
0 1 0 0 1 0 1 4 1 1 0 0
Interest 4 5 6 5 4 4 4 3 1 1 1 1
Depreciation 5 6 5 4 4 4 4 4 4 4 5 6
Profit before tax 10 -9 -6 2 3 -5 10 12 24 14 4 5
Tax % 37% 32% 33% 55% 39% 31% 30% 30% 29% 25% 8% 28%
6 -6 -4 1 2 -3 7 8 17 10 4 4
EPS in Rs 5.57 -5.39 -3.34 0.63 1.39 -2.82 6.02 7.41 14.95 9.07 3.61 3.14
Dividend Payout % 12% 0% 0% 0% 0% 0% 11% 14% 20% 33% 55% 48%
Compounded Sales Growth
10 Years: 3%
5 Years: -1%
3 Years: 0%
TTM: -10%
Compounded Profit Growth
10 Years: 10%
5 Years: -12%
3 Years: -41%
TTM: -13%
Stock Price CAGR
10 Years: %
5 Years: 29%
3 Years: -13%
1 Year: 11%
Return on Equity
10 Years: 10%
5 Years: 15%
3 Years: 9%
Last Year: 5%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 4 4 4 4 4 4 4 4 11 11 11 11
Reserves 37 31 26 27 28 25 33 39 49 56 57 58
47 43 45 37 33 31 28 16 10 3 6 12
40 48 34 35 20 25 37 30 21 18 32 37
Total Liabilities 129 126 109 103 85 85 101 88 92 88 106 118
45 41 35 32 30 30 30 32 31 33 37 40
CWIP 1 1 1 1 1 1 2 0 1 1 2 1
Investments 0 0 0 0 0 0 0 0 0 0 0 0
83 83 72 69 54 54 69 56 60 53 66 77
Total Assets 129 126 109 103 85 85 101 88 92 88 106 118

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
5 9 9 14 9 5 12 21 23 2 12 4
-13 -2 -1 0 -0 -3 -4 -5 -3 7 -10 -7
6 -6 -8 -14 -9 -2 -5 -17 -7 -12 -2 3
Net Cash Flow -1 2 -1 -0 0 0 2 -1 13 -3 0 -0

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 64 102 103 95 97 95 97 68 62 78 96 117
Inventory Days 113 133 123 166 145 126 92 75 100 91 96 150
Days Payable 82 132 106 128 123 130 120 97 81 50 98 144
Cash Conversion Cycle 94 104 120 133 119 92 68 46 80 118 93 123
Working Capital Days 88 109 113 100 88 93 78 70 76 107 86 111
ROCE % 18% -5% 0% 9% 10% -1% 21% 25% 39% 21% 7%

Shareholding Pattern

Numbers in percentages

6 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
63.39% 63.39% 63.39% 63.39% 63.51% 63.51% 63.51% 63.58% 63.58% 63.58% 63.60% 63.84%
36.61% 36.61% 36.61% 36.61% 36.49% 36.48% 36.49% 36.42% 36.42% 36.43% 36.41% 36.16%
No. of Shareholders 4,2284,5894,6424,5584,7094,6484,7704,8245,1075,6055,7525,877

Documents

Announcements

Annual reports

Credit ratings